Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Therapy-Associated Immunosuppression and Opportunistic Infections in Multiple Myeloma Patients.

Philipp Schutt, Dieter Brandhorst, Werner Stellberg, Miriam Poser, Peter Ebeling, Siemke Muller, Ulrike Buttkereit, Bertram Opalka, Monika Lindemann, Hans Grosse-Wilde, Siegfried Seeber, Thomas Moritz, Mohammad R. Nowrousian

Blood (2005) 106 (11): 5137.

https://doi.org/10.1182/blood.V106.11.5137.5137

Published: 2005

Journal Articles

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias

Dietrich W. Beelen, Hellmut D. Ottinger, Stanislav Ferencik, Ahmet H. Elmaagacli, Rudolf Peceny, Rudolf Trenschel, Hans Grosse-Wilde

Blood (2005) 105 (6): 2594–2600.

https://doi.org/10.1182/blood-2004-04-1441

Published: 2005

Journal Articles

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

Holger Nückel, Vera Rebmann, Jan Dürig, Ulrich Dührsen, Hans Grosse-Wilde

Blood (2005) 105 (4): 1694–1698.

https://doi.org/10.1182/blood-2004-08-3335

Published: 2005

Journal Articles

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Ahmet H. Elmaagacli, MD, Hellmut Ottinger, MD, Koldehoff Michael, MD, Peceny Rudolf, MD, Nina K. Steckel, MD, Rudolf Trenschel, MD, Harald Biersack, MD, Hans Grosse-Wilde, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 974.

https://doi.org/10.1182/blood.V104.11.974.974

Published: 2004

Journal Articles

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors

Hellmut D. Ottinger, Stanislav Ferencik, Dietrich W. Beelen, Monika Lindemann, Rudolf Peceny, Ahmed H. Elmaagacli, Johannes Hüsing, Hans Grosse-Wilde

Blood (2003) 102 (3): 1131–1137.

https://doi.org/10.1182/blood-2002-09-2866

Published: 2003

Journal Articles

Outcome of transplantation of highly purified peripheral blood CD34 + cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia

Ahmet H. Elmaagacli, Rudolf Peceny, Nina Steckel, Rudolf Trenschel, Hellmut Ottinger, Hans Grosse-Wilde, Ulrich W. Schaefer, Dietrich W. Beelen

Blood (2003) 101 (2): 446–453.

https://doi.org/10.1182/blood-2002-05-1615

Published: 2003

Journal Articles

Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia

Ahmet H. Elmaagacli, Semiha Basoglu, Rudolf Peceny, Rudolf Trenschel, Hellmut Ottinger, Andre Lollert, Volker Runde, Hans Grosse-Wilde, Dietrich W. Beelen, Ulrich W. Schaefer

Blood (2002) 99 (4): 1130–1135.

https://doi.org/10.1182/blood.V99.4.1130.h8001130_1130_1135

Published: 2002

Journal Articles

Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism

Dietrich W. Beelen, Helmut D. Ottinger, Ahmet Elmaagacli, Birgit Scheulen, Oliver Basu, Bernhard Kremens, Werner Havers, Hans Grosse-Wilde, Ulrich W. Schaefer

Blood (1997) 90 (12): 4725–4735.

https://doi.org/10.1182/blood.V90.12.4725

Published: 1997

NARROW

Therapy-Associated Immunosuppression and Opportunistic Infections in Multiple Myeloma Patients.

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors

Outcome of transplantation of highly purified peripheral blood CD34 + cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia

Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia

Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only